KamalGuptaMD
Cardiology • Kansas City, KSAdult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology
Professor, Division of Cardiovascular Diseases University Kansas School of Medicine
Dr. Gupta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4000 Cambridge St
Ste G600
Kansas City, KS 66160Phone+1 913-588-9600Fax+1 913-588-9770
Education & Training
Baylor College of MedicineFellowship, Interventional Cardiology, 2003 - 2004- Baylor College of MedicineFellowship, Cardiovascular Disease, 2000 - 2003
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1997 - 1999
All India Institute of Medical SciencesClass of 1994
Certifications & Licensure
MO State Medical License 2005 - 2026
KS State Medical License 2004 - 2025
TX State Medical License 2018 - 2018
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Top MD Consumers Checkbook
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Ischemic Preconditioning to Prevent Acute Kidney Injury Start of enrollment: 2014 Jun 01
Publications & Presentations
PubMed
- Endovascular Abdominal Aortic Aneurysm Repair.Zafar Ali, Luke Kim, Kamal Gupta
Interventional Cardiology Clinics. 2025-04-01 - Prognostic value of the Hospital Frailty Risk Score (HFRS) and outcomes in peripheral artery disease and end-stage kidney disease.Monil Majmundar, Chan Wan-Chi, Kunal N Patel, Vidit Majmundar, Rhythm Vasudeva
Vascular Medicine. 2025-03-13 - Pulmonary Embolism in Patients with End-Stage Kidney Disease Starting Dialysis.Kunal N Patel, Wan-Chi Chan, Vivek Bhat, Monil M Majmundar, Harsh Mehta
JAMA Network Open. 2025-03-03
Press Mentions
Normalizing Testosterone with Replacement Therapy Reduced Atrial Fibrillation RiskMay 24th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
